首页 500强 活动 榜单 商业 科技 商潮 专题 品牌中心
杂志订阅

到2050年,全球或将有一半人口患有糖尿病

Ian Mount
2025-05-28

人工智能技术能够帮助糖尿病患者实时掌握食物成分及潜在血糖反应。

文本设置
小号
默认
大号
Plus(0条)

罗氏制药中东地区负责人奥法特·贝罗;信诺医疗保健中东和非洲(不含沙特)首席执行官利亚·科特里尔;以及January AI公司创始人兼首席执行官诺辛·哈希米(从左到右)。 图片来源:Iman Al-dabbagh—Fortune

• 据预测,到本世纪中叶,全球糖尿病患者将达13亿人,若计入糖尿病前期人群,这一数字将攀升至50亿。当前,人工智能技术能够帮助糖尿病患者实时掌握食物成分及潜在血糖反应;未来,人工智能还将助力预测患者可能罹患的病症,并指导采取早期干预措施。

在利雅得召开的《财富》“全球最具影响力商界女性”峰会上,医疗行业领袖们指出,人工智能将在防治糖尿病相关疾病方面扮演日益重要的角色,尤其是存在大量生活方式相关糖尿病患者的中东等地区。

人工智能健康平台January AI创始人兼首席执行官诺辛·哈希米指出:“数据触目惊心。至2050年,全球糖尿病患者将达到13亿,而糖尿病前期人群规模约为这个数字的三倍。……这意味着超50亿人将出现胰岛素抵抗,占全球半数人口。”该平台通过人工智能技术提供个性化营养建议与血糖监测分析。

哈希米补充道:“好消息是,我们如今已掌握了改善全球代谢健康的必要工具。”她举例称,借助人工智能技术,用户仅需拍摄食物照片,即可了解食物中蛋白质、膳食纤维、碳水化合物等成分的含量,并预判食用后的血糖反应。

罗氏制药(Roche Pharmaceuticals)中东地区负责人奥法特·贝罗强调,未来结合基因组分析数据进行训练的人工智能预测能力,将实现对糖尿病患者更多疾病的诊断甚至预防。

贝罗表示:“我们已观察到糖尿病对其他健康指标的影响,如视力损害及患者未来可能面临的并发症。关键在于如何运用技术捕捉眼部变化等病变征兆,从而预测潜在疾病并实施早期干预。”

为开发无需监测设备的血糖管理应用程序,January AI收集了1,022名多样化受试者的研究数据,构建预测模型引擎。哈希米指出,通过整合个人基因组数据、生活方式信息及健康指标,人工智能现在可以利用这些更加个性化的数据有效“预测未来的健康状况”。

信诺医疗保健(Cigna Healthcare)中东及非洲(不含沙特)首席执行官利亚·科特里尔认为,此类人工智能健康监测技术及其提供的信息,有望避免全球半数人口罹患糖尿病或处于糖尿病前期的趋势。

她表示:“希望通过健康教育、神奇的人工智能工具以及药物研发的协同作用,能够在一定程度上压低发病率飙升曲线,避免这种可怕的情况发生。”(财富中文网)

译者:刘进龙

审校:汪皓

• 据预测,到本世纪中叶,全球糖尿病患者将达13亿人,若计入糖尿病前期人群,这一数字将攀升至50亿。当前,人工智能技术能够帮助糖尿病患者实时掌握食物成分及潜在血糖反应;未来,人工智能还将助力预测患者可能罹患的病症,并指导采取早期干预措施。

在利雅得召开的《财富》“全球最具影响力商界女性”峰会上,医疗行业领袖们指出,人工智能将在防治糖尿病相关疾病方面扮演日益重要的角色,尤其是存在大量生活方式相关糖尿病患者的中东等地区。

人工智能健康平台January AI创始人兼首席执行官诺辛·哈希米指出:“数据触目惊心。至2050年,全球糖尿病患者将达到13亿,而糖尿病前期人群规模约为这个数字的三倍。……这意味着超50亿人将出现胰岛素抵抗,占全球半数人口。”该平台通过人工智能技术提供个性化营养建议与血糖监测分析。

哈希米补充道:“好消息是,我们如今已掌握了改善全球代谢健康的必要工具。”她举例称,借助人工智能技术,用户仅需拍摄食物照片,即可了解食物中蛋白质、膳食纤维、碳水化合物等成分的含量,并预判食用后的血糖反应。

罗氏制药(Roche Pharmaceuticals)中东地区负责人奥法特·贝罗强调,未来结合基因组分析数据进行训练的人工智能预测能力,将实现对糖尿病患者更多疾病的诊断甚至预防。

贝罗表示:“我们已观察到糖尿病对其他健康指标的影响,如视力损害及患者未来可能面临的并发症。关键在于如何运用技术捕捉眼部变化等病变征兆,从而预测潜在疾病并实施早期干预。”

为开发无需监测设备的血糖管理应用程序,January AI收集了1,022名多样化受试者的研究数据,构建预测模型引擎。哈希米指出,通过整合个人基因组数据、生活方式信息及健康指标,人工智能现在可以利用这些更加个性化的数据有效“预测未来的健康状况”。

信诺医疗保健(Cigna Healthcare)中东及非洲(不含沙特)首席执行官利亚·科特里尔认为,此类人工智能健康监测技术及其提供的信息,有望避免全球半数人口罹患糖尿病或处于糖尿病前期的趋势。

她表示:“希望通过健康教育、神奇的人工智能工具以及药物研发的协同作用,能够在一定程度上压低发病率飙升曲线,避免这种可怕的情况发生。”(财富中文网)

译者:刘进龙

审校:汪皓

• Some 1.3 billion people are predicted to have diabetes by the middle of the century. That number hits 5 billion when pre-diabetic people are included. Artificial intelligence now lets people with diabetes know the composition of their food—and their likely blood sugar response to it. Soon, it will allow them to predict which diseases they will face in the future, and take early actions to avoid them.

Artificial intelligence will play an increasingly important role in preventing and treating diseases related to diabetes—especially in regions with large lifestyle-related diabetic populations such as the Middle East—a panel of health industry leaders told Fortune’s Most Powerful Women International conference in Riyadh.

“The numbers are staggering. We are going to have 1.3 billion people [around the globe] with diabetes by 2050 and about three times that number will have pre-diabetes. […] over 5 billion people, or half of the world population, will be insulin resistant,” said Noosheen Hashemi, founder and CEO of January AI, which uses AI to give personalized nutrition and blood sugar level insights.

“The good news is that we have all the tools we need today to help make the world metabolically healthy,” Hashemi added, pointing to AI-enabled technology that allows users to know the amount of protein, fiber, carbs and the like in a food—and their likely blood sugar response to it—just by taking a picture of it.

Olfat Berro, Roche Pharmaceuticals’ Middle East area head, noted that in the future the predictive power of AI, fed with genomic profiling data, will allow much more diseases to be diagnosed and even prevented in people with diabetes.

“We see the repercussions of this epidemic on other health factors, like, for example, on eyesight and the challenges that the patients might face in the future,” Berro said. “And one very important aspect…is how can we use technology to really understand what are the changes, for example, in the eyes that can we can predict what the diseases could be, and at the same time, we can intervene early on.”

To build its blood sugar monitoring app—which does not require a monitor—January AI harvested data from a study of 1,022 diverse participants, which allowed it to build a prediction engine. Hashemi said that with more personalized data from one person—combining genomic data, lifestyle information, and health metrics—AI can now effectively “predict the future of your health.”

The arrival of such AI health monitoring—and the information it provides—could help prevent a future in which half of the world’s population is diabetic or pre-diabetic, suggested Leah Cotterill, Cigna Healthcare’s CEO of Middle East and Africa (outside Saudi Arabia).

“One would hope that, with education and with fabulous AI tools and pharmaceuticals as well, you would be able to sort of dip that curve, rather than seeing that rise to such an extent,” she said.

财富中文网所刊载内容之知识产权为开云登陆入口及/或相关权利人专属所有或持有。未经许可,禁止进行转载、摘编、复制及建立镜像等任何使用。
0条Plus
精彩评论
评论

撰写或查看更多评论

请打开财富Plus APP

前往打开